Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-marketing Observational Study on the Safety and Efficacy of Fibryga in Congenital Fibrinogen Deficiency

NCT03793426 is registered in ClinicalTrials.gov with Octapharma as lead sponsor.

NCT NCT03793426
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03793426 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-marketing Observational Study on the Safety and Efficacy of Fibryga in Congenital Fibrinogen Deficiency
Lead sponsor
Octapharma
Phase
Observational
Overall status
Terminated
Start date
January 28, 2021
Completion date
May 14, 2025
Enrollment
7 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

congenital fibrinogen deficiency